PMC:7025910 / 3785-4031
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 92 | 30-49 | Chemical | denotes | lopinavir/ritonavir | MESH:C558899 |
| 93 | 100-119 | Chemical | denotes | Lopinavir/ritonavir | MESH:C558899 |
| 94 | 188-197 | Chemical | denotes | lopinavir | MESH:D061466 |
| 95 | 205-214 | Chemical | denotes | ritonavir | MESH:D019438 |
| 97 | 89-97 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T9 | 30-49 | Chemical | denotes | lopinavir/ritonavir | http://purl.obolibrary.org/obo/CHEBI_145924 |
| T10 | 30-39 | Chemical | denotes | lopinavir | http://purl.obolibrary.org/obo/CHEBI_31781 |
| T11 | 40-49 | Chemical | denotes | ritonavir | http://purl.obolibrary.org/obo/CHEBI_45409 |
| T12 | 51-58 | Chemical | denotes | Kaletra | http://purl.obolibrary.org/obo/CHEBI_145924 |
| T13 | 100-109 | Chemical | denotes | Lopinavir | http://purl.obolibrary.org/obo/CHEBI_31781 |
| T14 | 110-119 | Chemical | denotes | ritonavir | http://purl.obolibrary.org/obo/CHEBI_45409 |
| T15 | 188-197 | Chemical | denotes | lopinavir | http://purl.obolibrary.org/obo/CHEBI_31781 |
| T16 | 205-214 | Chemical | denotes | ritonavir | http://purl.obolibrary.org/obo/CHEBI_45409 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T31 | 0-246 | Sentence | denotes | There were some reports about lopinavir/ritonavir (Kaletra, AbbVie) for the treatment of COVID-19.1 Lopinavir/ritonavir was started from the hospital day 8 (day 10 of illness); 2 tablets (lopinavir 200 mg/ritonavir 50 mg) were given per oral bid. |